Alida Biosciences raised $7.5M in a Series A funding led by Genoa Ventures and Early Access Launch of Innovative Products for Epitranscriptomic Research
Alida Biosciences raised $7.5M in a Series A funding led by Genoa Ventures and Early Access Launch of Innovative Products for Epitranscriptomic Research
06/12/24, 9:04 AM
Location
san diegoMoney raised
$7.5 million
Industry
biotechnology
Round Type
series a
Investors
Vertical Venture Partners, Fusion X Ventures, Genoa Ventures
Alida Biosciences has successfully completed a $7.5 million Series A funding round led by Genoa Ventures, with participation from FusionX Ventures and Vertical Venture Partners. The funding is complemented by two ongoing SBIR grants totaling $4 million from The National Human Genome Research Institute (NHGRI). In addition, AlidaBio has unveiled the Early Access launch of two products: the EpiPlex™ RNA Library Prep Kit and the EpiScout™ Analysis Suite.